School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

COOPER COMPANIES, INC. COO

Healthcare · Medical Instruments & Supplies

$54.37last close 2026-10-09 · market cap $10.34B · delayed data

Trailing returns

1M-14.35%
3M-23.44%
6M-23.92%
1Y-22.05%
5Y-47.01%

Basis: Adjusted daily closes.

What it does

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.

Open COO in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies